Bala Mohan
SVP, Chief Development Officer at Mersana Therapeutics, Inc.
- Sold, on record
- $49k
- Dollars the filings state
- Form 4 sales
- 7
- Latest Oct 27, 2025
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Mersana Therapeutics, Inc.SVP, Chief Development Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice Mersana Therapeutics, Inc.NoticeOct 7, 2024 2024
Filed to sell 13,687 shares ($28k)
Bala Mohan, Officer
10b5-1 plan4x usual sizeFiling
- 2 Form 4 sale Mersana Therapeutics, Inc.RoutineOct 28, 2024 +21 days
Sold 1,884 shares at $1.90 ($4k)
Bala Mohan, SVP, Chief Development Officer
10b5-1 planSold 3.3% of holdings ($108k position)54,731 shares left0.5x usual sizeFollows a Form 144Filing
- 3 Form 144 notice Mersana Therapeutics, Inc.NoticeOct 29, 2024 +1 day
Filed to sell 1,884 shares ($4k)
Bala Mohan, Officer
10b5-1 plan0.7x usual sizeFiling
- 4 Form 4 sale Mersana Therapeutics, Inc.RoutineJan 14, 2025 +77 days
Sold 3,253 shares at $0.66 ($2k)
Bala Mohan, SVP, Chief Development Officer
10b5-1 planSold 5.1% of holdings ($42k position)60,228 shares left1.2x usual sizeFollows a Form 144Filing
- 5 Form 4 sale Mersana Therapeutics, Inc.RoutineJan 16, 2025 +2 days
Sold 5,939 shares at $0.58 ($3k)
Bala Mohan, SVP, Chief Development Officer
10b5-1 planSold 7.9% of holdings ($43k position)68,872 shares left1.8x usual sizeFiling
- 6 Form 144 notice Mersana Therapeutics, Inc.NoticeJan 17, 2025 +1 day
Filed to sell 3,253 shares ($2k)
Bala Mohan, Officer
10b5-1 plan1x usual sizeFiling
- 7 Form 144 notice Mersana Therapeutics, Inc.NoticeJan 17, 2025 same day
Filed to sell 5,939 shares ($4k)
Bala Mohan, Officer
10b5-1 plan1.8x usual sizeFiling
- 8 Form 4 sale Mersana Therapeutics, Inc.RoutineOct 27, 2025 +283 days
Sold 77 shares at $9.90 ($762)
Bala Mohan, SVP, Chief Development Officer
10b5-1 planSold 2.6% of holdings ($30k position)2,922 shares left0x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2025 | Oct 28, 2025 | Mersana Therapeutics, Inc. | SVP, Chief Development Officer | Form 4 sale | 77 | $762 | 2.6% | Routine | SEC |
| Jan 17, 2025 | Jan 17, 2025 | Mersana Therapeutics, Inc. | Officer | Form 144 notice | 5,939 | $4k | Notice | SEC | |
| Jan 17, 2025 | Jan 17, 2025 | Mersana Therapeutics, Inc. | Officer | Form 144 notice | 3,253 | $2k | Notice | SEC | |
| Jan 16, 2025 | Jan 17, 2025 | Mersana Therapeutics, Inc. | SVP, Chief Development Officer | Form 4 sale | 5,939 | $3k | 7.9% | Routine | SEC |
| Jan 14, 2025 | Jan 15, 2025 | Mersana Therapeutics, Inc. | SVP, Chief Development Officer | Form 4 sale | 3,253 | $2k | 5.1% | Routine | SEC |
| Oct 29, 2024 | Oct 29, 2024 | Mersana Therapeutics, Inc. | Officer | Form 144 notice | 1,884 | $4k | Notice | SEC | |
| Oct 28, 2024 | Oct 29, 2024 | Mersana Therapeutics, Inc. | SVP, Chief Development Officer | Form 4 sale | 1,884 | $4k | 3.3% | Routine | SEC |
| Oct 7, 2024 | Oct 7, 2024 | Mersana Therapeutics, Inc. | Officer | Form 144 notice | 13,687 | $28k | Notice | SEC | |
| Oct 3, 2024 | Oct 7, 2024 | Mersana Therapeutics, Inc. | SVP, Chief Development Officer | Form 4 sale | 13,687 | $27k | 21.4% | Routine | SEC |
| Jan 16, 2024 | Jan 17, 2024 | Mersana Therapeutics, Inc. | SVP, Chief Development Officer | Form 4 sale | 3,431 | $9k | 19.6% | Routine | SEC |
| Jan 16, 2024 | Jan 16, 2024 | Mersana Therapeutics, Inc. | Officer | Form 144 notice | 3,431 | $10k | Notice | SEC | |
| Oct 26, 2023 | Oct 27, 2023 | Mersana Therapeutics, Inc. | SVP, Chief Development Officer | Form 4 sale | 1,912 | $2k | 18.0% | Routine | SEC |